2013
DOI: 10.1016/j.annepidem.2012.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality

Abstract: Purpose To evaluate the associations of high sensitivity Troponin T (Hs-TnT), N-terminal pro-brain natriuretic peptide (NT-proBNP), and high sensitivity C-reactive protein (Hs-CRP) with mortality from any cause, cardiovascular disease (CVD), coronary heart disease (CHD), stroke, cancer, and respiratory disease in the Atherosclerosis Risk in Communities (ARIC) cohort. Methods 11193 participants aged 54-74 years, initially free of the conditions being studied, had biomarkers measured and were followed for a me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
59
2
3

Year Published

2014
2014
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 72 publications
(69 citation statements)
references
References 51 publications
5
59
2
3
Order By: Relevance
“…18 Interestingly, a longitudinal populationbased study showed that elevated cTn at baseline not only predicted cardiovascular death within the 10-year follow-up period (HR, 7.4; 95% CI, 4.6-11.6) but to a lower degree also death from stroke (HR, 3.3; 95% CI, 1.3-8.7), and cancer (HR, 1.6; 95% CI, 1.1-2.4). 56 Furthermore, cTn was independently associated with increased risk of incident stroke in the general population (HR, 1.13; 95% CI, 1.1-1.2; follow-up 20 years). 58 In patients with atrial fibrillation included in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, annual rates of stroke or systemic embolism during follow-up of 2 years ranged from 0.9% in the lowest cTn quartile to 2.1% in the highest quartile (HR, 1.9; 95% CI, 1.4-2.8).…”
Section: Future Perspectives: Possible Applicationsmentioning
confidence: 95%
See 2 more Smart Citations
“…18 Interestingly, a longitudinal populationbased study showed that elevated cTn at baseline not only predicted cardiovascular death within the 10-year follow-up period (HR, 7.4; 95% CI, 4.6-11.6) but to a lower degree also death from stroke (HR, 3.3; 95% CI, 1.3-8.7), and cancer (HR, 1.6; 95% CI, 1.1-2.4). 56 Furthermore, cTn was independently associated with increased risk of incident stroke in the general population (HR, 1.13; 95% CI, 1.1-1.2; follow-up 20 years). 58 In patients with atrial fibrillation included in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, annual rates of stroke or systemic embolism during follow-up of 2 years ranged from 0.9% in the lowest cTn quartile to 2.1% in the highest quartile (HR, 1.9; 95% CI, 1.4-2.8).…”
Section: Future Perspectives: Possible Applicationsmentioning
confidence: 95%
“…This recommendation is based on the strong association between cTn levels and (subclinical) heart disease, future cardiovascular events and mortality. 16,17,56 If there is evidence of acute ischemic myocardial injury (dynamic pattern), clinicians should promptly attempt to identify the most probable cause of cTn elevation. 4,52 The pretest probability for MI increases with the presence of cardiovascular risk factors, ECG alterations suggestive of myocardial ischemia, typical chest discomfort, or dyspnea.…”
Section: Clinical Work-up Of Stroke Patients With Elevated Ctnmentioning
confidence: 99%
See 1 more Smart Citation
“…[3][4][5][6][7][8][9][10] In addition, elevated hs-CRP has been shown to be a stronger predictor of cardiovascular disease than low-density lipoprotein cholesterol.…”
Section: S C I E N T I F I C I N V E S T I G a T I O N Smentioning
confidence: 99%
“…2 Elevated hs-CRP levels have been associated with infl ammation, aging, cancer, adverse outcomes of angina pectoris, coronary artery disease, adverse outcomes of chronic obstructive pulmonary disease, stroke, and increased risk of mortality. [3][4][5][6][7][8][9][10] In addition, elevated hs-CRP has been shown to be a stronger predictor of cardiovascular disease than low-density lipoprotein cholesterol. 11 A recent study of more than 4,000 subjects followed for six years revealed that elevated hs-CRP was associated with type 2 diabetes.…”
Section: S C I E N T I F I C I N V E S T I G a T I O N Smentioning
confidence: 99%